

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.


Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.

The recent IRS admissions about the use of "Tea Party" or "Patriot" labels to flag applications for nonprofit status for additional scrutiny raise serious questions about political bias, and should receive a thorough and independent investigation.
Yesterday, Common Cause joined the growing call for House and Senate hearings to answer those questions, but stressed the need for those hearings to delve deeper into the bigger problem facing our democracy after the Supreme Court's decision in Citizen United - the dramatic surge in the misuse of nonprofits to hide political spending by billionaires and corporations from American voters, and the lack of any meaningful enforcement response.
Common Cause has a long history of standing up for apolitical enforcement of the nation's tax laws, dating back to the days when key Common Cause leaders were on Nixon's enemies list. In a March 2012 press release accompanying a complaint to the IRS challenging the tax status of Liberty Central, then-president Bob Edgar stated that:
Common Cause supports the efforts of the IRS to investigate all groups, regardless of their partisan leanings, that appear to use nonprofit status to hide their political activities from American voters. Special interests should not be permitted to use front groups to evade disclosure laws designed to inform voters and prevent corruption.
Although the IRS must enforce the law impartially, the agency should not abrogate its responsibility to enforce it in the first place. While Common Cause strongly supports an investigation, we are concerned that partisans on both sides will use this tempest to cow the IRS and forestall enforcement of the tax code.
"Social Welfare" Political Spending Surges in the 2012 Election
Reported political spending by 501(c)(4)s - the kind of group at the focus of this controversy - surged to $254 million in 2012, almost matching spending by political parties ($255 million), according to the Center for Responsive Politics, thanks in large part to the Supreme Court's decision in Citizens United. The vast majority of that spending - 85 percent - came from conservative organizations, led by Karl Rove's Crossroads GPS and Americans for Prosperity, backed by the Koch brothers. Given this disproportionate spending on behalf of conservative candidates at this point in history, most of the groups flagged will logically be conservative organizations, even using impartial criteria.
It is patently obvious to American voters that many of these groups, on the left and right, have been formed in order to hide political spending by mega-donors who want to influence the outcome of elections while keeping their identities secret.
There is also no getting around the fact that the IRS search criteria at the heart of the current controversy were developed at a time when billionaire political players, led by the Koch brothers and Rupert Murdoch, were bankrolling Tea Party groups. In 2010, there were 129 candidates for Congress and nine Senate candidates running for office under the Tea Party label. The primary focus for many of those groups was taking out Members of Congress who voted for the Affordable Care Act, and they played a major role in flipping the U.S. House to Republican control in 2010. Some of the groups evaporated soon after the elections were over.
Targeting groups that have applied for tax-exempt status for additional scrutiny because they appear to have an electoral motive is proper - as long as the same criteria is applied to all regardless of political viewpoints. At a time of unprecedented use of nonprofit organizations to funnel money for use in political campaigns, we need more enforcement to prevent evasion of campaign, disclosure and tax laws, not less.
Common Cause filed a complaint in March 2012 to the IRS about one of those organizations in 2012 - Liberty Central - founded by Justice Thomas' wife Ginni Thomas while he was still deliberating on Citizens United. Based on our research, the primary purpose of that group was to elect Tea Party candidates for Congress in 2010 and defeat Members who had voted for the Affordable Care Act. Ms. Thomas spent much of her time flying to Tea Party events and rallies, expressly called for the election of certain candidates, and featured a candidate scorecard on her website. Ms. Thomas left the group shortly after the elections, and its activity evaporated. Common Cause challenge to Liberty Central's tax status produced no visible action by the IRS, nor did similar complaints from the Campaign Legal Center and Democracy 21 against other groups on both sides of the political spectrum.
Time for Reform
The current IRS controversy does not excuse sham political organizations masquerading as social welfare organizations, and shines a light on the critical need for campaign spending disclosure legislation. The increased pressure on the IRS is a direct result of the abysmal failure of Congress and the FEC to enact or adopt common sense disclosure rules, despite the Supreme Court majority's assurance that disclosure would allow voters (and shareholders) to make informed decisions.
The crisis is also a product of the fuzzy "primary purpose" test, based on facts and circumstances, that the IRS has long used to determine if a c4 is violating its nonprofit social welfare status. Vague standards don't work in the world of campaign finance and, given the increased politicization of nnprofits, they are ill suited to the world of tax law as well. It is time for Congress to adopt a bright-line test for deciding when political activity by nonprofits requires a group to form a "527" political organization and disclose its donors.
Common Cause is concerned that instead of moving the ball forward, partisans will use the current controversy to intimidate the IRS from ever enforcing nonprofit tax laws when, in fact, the larger problem here is already inadequate enforcement. The IRS backed off enforcement of the gift tax on large contributions to c4s in 2011 after a political backlash. Will the same thing happen here with enforcement of c4 limits on political activity? It will take a concerted effort by reform advocates and the media for the "Tea Party" controversy to move the country forward instead of backward.v
Common Cause is a nonpartisan, grassroots organization dedicated to upholding the core values of American democracy. We work to create open, honest, and accountable government that serves the public interest; promote equal rights, opportunity, and representation for all; and empower all people to make their voices heard in the political process.
(202) 833-1200"Trump, Putin, and Xi can and must put the world on a safer path by taking commonsense actions to build down the nuclear danger," said one campaigner.
Secretary of State Marco Rubio on Wednesday implicitly confirmed that New START—a key arms control treaty between the United States and Russia—will expire Thursday, prompting renewed demands for what one group called "a more coherent approach from the Trump administration" toward nuclear nonproliferation.
Asked about the impending expiration of New START during a Wednesday press conference, Rubio said he didn't "have any announcement" on the matter, and that President Donald Trump "will opine on it later."
"Obviously, the president’s been clear in the past that in order to have true arms control in the 21st century, it’s impossible to do something that doesn’t include China because of their vast and rapidly growing stockpile," Rubio said.
🇺🇸🇷🇺🇨🇳 Secretary of State Marco Rubio:
I don't have any announcement on New START right now. I think the President will opine on it later.
The President has been clear in the past that in order to have true arms control in the 21st century, it's impossible to do something that… pic.twitter.com/8pxi3bfdsy
— Visioner (@visionergeo) February 4, 2026
New START, signed in 2010, committed the United States and Russia to halving the number of strategic nuclear missile launchers in their arsenals. While the treaty did not limit the size of the countries' actual nuclear arsenals, proponents pointed to its robust verification regime and other transparency features as mutually beneficial highlights of the agreement.
“We have known that New START would end for 15 years, but no one has shown the necessary leadership to be prepared for its expiration,” said John Erath, senior policy director at the Center for Arms Control and Non-Proliferation and former longtime State Department official.
“The treaty limited the number of nuclear weapons the United States and Russia could have, but perhaps more importantly, New START also provided each country with unprecedented insights into the other’s arsenal so that Washington and Moscow could make decisions based on real information rather than speculation," Erath added.
The last remaining major treaty limiting the world's two largest nuclear arsenals expires Feb. 5. Does this mean the end of nuclear arms control? Not necessarily. Read our statement.armscontrolcenter.org/statement-on...
[image or embed]
— Nukes of Hazard (@nukesofhazard.bsky.social) February 4, 2026 at 2:04 PM
Daryl G. Kimball, executive director of the Arms Control Association, said Wednesday that "the end of New START requires a more coherent approach from the Trump administration."
"If President Trump and Secretary Rubio are serious, they should make a serious proposal for bilateral (not trilateral) talks with Beijing," he asserted. "Despite Trump’s talk about involving China in nuclear negotiations, there is no indication that Trump or his team have taken the time to propose risk reduction or arms control talks with China since returning to office in 2025."
Kimball continued:
Furthermore, there is no reason why the United States and Russia should not and cannot continue, as [Russian President Vladimir] Putin suggested on September 22, to respect the central limits of New START and begin the hard work of negotiating a new framework agreement involving verifiable limits on strategic, intermediate-range, and short-range nuclear weapons, as well as strategic missile defenses.
At the same time, if he is serious about involving China in “denuclearization” talks, he could and should invite [Chinese President Xi Jinping] when they meet later this year, to agree to regular bilateral talks on risk reduction and arms control involving senior Chinese and US officials.
"With the end of New START, Trump, Putin, and Xi can and must put the world on a safer path by taking commonsense actions to build down the nuclear danger," Kimball added.
Erath lamented that "with New START’s expiration, we have not only lost unprecedented verification measures that our military and decision-makers depended on, but we have ended more than five decades of painstaking diplomacy that successfully avoided nuclear catastrophe."
"Agreements preceding New START helped reduce the global nuclear arsenal by more than 80% since the height of the Cold War,"
he noted. "Now, both Russia and the United States have no legal obstacle to building their arsenals back up, and we could find ourselves reliving the Cold War."
Last week, the Bulletin of the Atomic Scientists’ Science and Security Board advanced its symbolic Doomsday Clock to 85 seconds to midnight, the closest it has ever been to global thermonuclear annihilation, citing developments including failure to extend New START, China's growing arsenal, and Russian weapons tests—to which Trump has vowed to respond in kind.
"The good news is," said Erath, is that "the end of New START does not have to mean the end of nuclear arms control."
"While New START can’t be extended beyond today, Presidents Donald Trump and Vladimir Putin could decide to respect the numerical limits the treaty set on nuclear arsenals," he explained. "They could also resume the treaty’s data exchanges and on-site inspections, in addition to implementing verification measures from other previous arms control treaties."
"Further, they could instruct their administrations to begin immediate talks on a new treaty to cover existing and novel systems and potentially bring in other nuclear powers, like China," Erath continued. "Meanwhile, Congress could—and should—fund nonproliferation and global monitoring efforts while refusing to fund dangerous new nuclear weapons systems."
Last December, US Sens. Ed Markey (D-Mass.) and Jeff Merkley (D-Ore.) and Reps. Don Beyer (D-Va.), John Garamendi (D-Calif.), and Jim McGovern (D-Mass.) reintroduced the bicameral Hastening Arms Limitation Talks (HALT) Act, "legislation outlining a vision for a 21st century freeze on the testing, production, and deployment of nuclear weapons."
"The Doomsday Clock is at 85 seconds to midnight," Markey—who co-chairs the congressional Nuclear Weapons and Arms Control Working Group—said Wednesday ahead of a press conference with HALT Act co-sponsors. "We need to replace New START now."
"Every single ICE and CBP agent should be out of Minnesota," the congresswoman said. "The terror campaign must stop."
President Donald Trump's "border czar," Tom Homan, announced Wednesday that 700 immigration agents are leaving Minnesota, but with around 2,000 expected to remain there, Democratic Congresswoman Ilhan Omar, whose district includes Minneapolis, declared that the drawdown is "not enough."
As part of Trump's "Operation Metro Surge," agents with Customs and Border Protection (CBP) and Immigration and Customs Enforcement (ICE) have invaded multiple Minnesota cities, including Minneapolis and Saint Paul, and committed various acts of violence, such as fatally shooting Alex Pretti and Renee Good.
In a pair of social media posts about Homan's announcement, Omar argued that "every single ICE and CBP agent should be out of Minnesota. The terror campaign must stop."
"This occupation has to end!" she added, also renewing her call to abolish ICE—a position adopted by growing shares of federal lawmakers and the public as Trump's mass deportation agenda has hit Minnesota's Twin Cities, the Chicago and Los Angeles metropolitan areas, multiple cities in Maine, and other communities across the United States.
In Congress, where a fight over funding for CBP and ICE's parent agency, the Department of Homeland Security, is playing out, Omar has stood with other progressives in recent votes. The bill signed by Trump on Tuesday only funds DHS through the middle of the month, though Republicans gave ICE an extra $75 billion in last year's budget package.
During an on-camera interview with NBC News' Tom Llamas, Trump said that the reduction of agents came from him. After the president's factually dubious rant about crime rates, Llamas asked what he had learned from the operation in Minnesota. Trump responded: "I learned that maybe we can use a little bit of a softer touch. But you still have to be tough."
"We're really dealing with really hard criminals," Trump added. Despite claims from him and others in the administration that recent operations have targeted "the worst of the worst," data have repeatedly shown that most immigrants detained by federal officials over the past year don't have any criminal convictions.
Operation Metro Surge has been met with persistent protests in Minnesota and solidarity actions across the United States. Jaylani Hussein, executive director of the Minnesota chapter of the Council on American-Islamic Relations, said Wednesday that "the limited drawdown of ICE agents from Minnesota is not a concession. It is a direct response to Minnesotans standing up to unconstitutional federal overreach."
"Minnesotans are winning against this attack on all our communities by organizing, resisting, and defending our constitutional rights. But this moment should not be a victory lap," Hussein continued. "It must instead be a call to continue pushing for justice. The deaths of Renee Good and Alex Pretti at the hands of federal immigration agents remain uninvestigated, and communities and prosecutors alike have raised grave concerns about violations of their oaths and the Constitution. This is not the time to pull back, it is the time to deepen our resilience, increase our support for one another, and keep fighting for our democracy and accountability until justice is served."
The Not Above the Law coalition's co-chairs—Praveen Fernandes of the Constitutional Accountability Center, Kelsey Herbert of MoveOn, Lisa Gilbert of Public Citizen, and Brett Edkins, of Stand Up America—similarly said that "Tom Homan's announcement that 700 federal immigration agents will be withdrawn from Minnesota is more a minor concession than a meaningful policy shift."
"The vast majority—approximately 2,000 federal agents—remain deployed in the state, and enforcement operations continue unabated," the co-chairs stressed. "This token gesture does nothing to address the ongoing terror families face or the constitutional crisis this administration's actions have created."
“The killings of Minnesotans demand real accountability," they added. "Families torn apart by raids and alleged constitutional violations deserve justice. Real change means the complete withdrawal of all federal forces conducting these operations in Minnesota, full accountability for the deaths and violations that have occurred, and congressional action to restore the rule of law. The American people deserve better than political theater when constitutional rights hang in the balance."
On Tuesday, the state and national ACLU asked the United Nations Committee on the Elimination of Racial Discrimination to "use its early warning and urgent action procedure in response to the human rights crisis following the Trump administration's deployment of federal forces" in the Twin Cities.
"The Trump administration's ongoing immigration enforcement operations in Minnesota are being carried out by thousands of masked federal agents in military gear who are ignoring basic constitutional and human rights of Minnesotans," said Teresa Nelson, legal director of the ACLU of Minnesota. "Their targeting of our Somali and Latino communities threatens Minnesotans’ most fundamental rights, and it has spread fear among immigrant communities and neighborhoods."
"When Big Pharma gets richer off the back of a grandmother struggling to pay for cancer medication, the system is broken."
Led by Senate Finance Committee Chair Ron Wyden, four Democratic senators on Wednesday outlined plans to reduce the costs of prescription drugs after President Donald Trump claimed he would do so—only to allow Big Pharma companies to delay negotiating lower prices and secure "zero commitments" from top executives on making lifesaving medications more affordable for millions of Americans.
“There is no greater fraud than Donald J. Trump when it comes to lower drug prices,” Wyden (D-Ore.) said. “Our doors are wide open to anybody who wants to take the bold next step forward on lowering drug costs for Americans."
Along with a "flash report" on Trump's "broken promises" regarding his pledge to bring drug prices down “to levels nobody ever thought was possible," Wyden sent a Dear Colleague letter to Democratic senators regarding his committee's plans to follow through with lowering costs.
"Finance Committee minority staff will dedicate substantial time and effort this year to developing the next generation of healthcare solutions that lower costs for American families," Wyden wrote. "These solutions will rein in Big Pharma’s outrageous price increases, lower costs for consumers, guarantee predictability for patients, and reduce wasteful government spending that pads the profits of big corporations. Alongside the co-signers of this letter, I invite you to be a part of this bold vision."
The letter, co-signed by Sens. Catherine Cortez Masto (D-Nev.), Peter Welch (D-Vt.), and Ruben Gallego (D-Ariz.), notes that "the only concrete drug pricing policy Trump enacted within the past year was a price hike for the biggest blockbuster cancer drugs on Earth, giving an $8.8 billion windfall to the pharmaceutical industry."
In contrast, the senators wrote, the Senate Finance Committee will develop policies to incorporate international pricing models into the Medicare drug price negotiation framework, including by allowing Health and Human Services Secretary Robert F. Kennedy Jr. to consider international prices as a factor or penalize drugmakers when pricing for US customers exceeds international benchmarks.
“Democrats are determined to bring prices down, and we’re willing to work with anyone to find concrete ways to do it."
The committee will also work to end Republican "blockbuster drug bailouts from negotiation," like the ones included in the One Big Beautiful Bill Act that shielded several high-priced drugs—including the cancer drug Keytruda—from Medicare price negotiations.
"The Republican budget bill contained a nearly $9 billion sweetheart deal that benefits the biggest drug companies by delaying or exempting some lifesaving medications from negotiation," reads the Democrats' flash report.
Gallego said that "when Big Pharma gets richer off the back of a grandmother struggling to pay for cancer medication, the system is broken."
"That’s what this is all about: Big Pharma execs sitting in their fancy corner offices profiting off of sick, working-class Americans,” the senator said. “We are not going to accept an America where millions of families live in fear of getting sick and needing to fill a prescription. We are going to fight and fight hard for a healthcare system that does what Donald Trump never did: actually lower costs for working families.”
The lawmakers emphasized that even if manufacturers are forced to lower drug prices, patients are not currently guaranteed to directly benefit, because as much as 45% of the $5.4 trillion the US spends on healthcare annually is "absorbed by middlemen such as insurers, pharmacy benefit managers (PBMs), and drug distributors."
"Healthcare middlemen profit when drug costs are high because they make money off of drug margin or payments that are linked to the price of a drug, ripping off patients who pay more than they should. Medicare Part D and the patients it serves should stop footing the bill for inflated drug prices and instead pay for drugs in a more transparent manner that reduces middleman margin," wrote the senators.
The Finance Committee will develop policies to eliminate abuses in the prescription drug supply chain including "egregious drug price markups," and to ensure that patient cost-sharing on drugs more closely aligns with the costs to plans and PBMs.
Finally, the Democrats said they would work to fix the "unmitigated disaster" that Trump and Kennedy have been "for innovation and drug development," as the administration has proposed slashing the National Institutes of Health budget by 40% and has cut off access to treatment for an estimated 74,000 patients who were enrolled in NIH clinical trials.
The Finance Committee, they said, plans to create new incentives for innovation and drug development, including through the tax code.
In their flash report, the Democrats wrote that while failing to force Big Pharma to the negotiating table to save money for Americans, Trump "has been parading Big Pharma executives through the White House, claiming to be cutting cost-saving deals with these corporations."
"One look under the hood reveals the truth: Trump is giving them a pass on tariffs, while receiving zero commitments about how they will lower costs for taxpayers and patients," they wrote. "Donald Trump is getting fleeced by Big Pharma CEOs, and Americans are going to foot the bill."
Welch said that the president "loves to talk a big game and make promises to working families about lowering prescription drug prices. But in reality, his administration is handling this like a PR problem: They’ve got to keep moving and talking about it, but then do nothing to really address the crisis."
“Democrats are determined to bring prices down, and we’re willing to work with anyone to find concrete ways to do it," said Welch. "We’re going to lower healthcare costs and ensure everyone can access affordable, lifesaving, and pain-relieving medication.”